Skip to main content
Sign in Create a free account
Varsity Tutors
Sign in

Sterile Preparations - NAPLEX

  1. A 62-year-old male (79 kg) with multiple myeloma is ordered cyclophosphamide 1,000 mg IV today (hazardous drug). Allergies: none. Labs: SCr 1.1 mg/dL, AST 26 units/L, ALT 24 units/L, WBC 3,200/mm3^3. Current medications: acyclovir 400 mg by mouth twice daily, allopurinol 300 mg by mouth daily. The dose will be compounded in a compounding aseptic containment isolator (CACI) located in a negative-pressure hazardous buffer room. Which personal protective equipment is required for this preparation?
    Answer: Two pairs of chemotherapy gloves and a chemotherapy gown; consider eye/face protection if splash risk exists The sterile preparation concept being tested is the appropriate personal protective equipment (PPE) required for compounding hazardous drugs (HDs) in a compounding aseptic containment isolator (CACI). The key preparation-specific factor is that cyclophosphamide is a hazardous antineoplastic drug, posing risks of dermal, inhalation, and mucosal exposure during compounding. Choice A is the best choice for ensuring sterile integrity and patient safety because it mandates two pairs of chemotherapy gloves and a chemotherapy gown to minimize dermal absorption and contamination, while considering eye/face protection for splash risks as per USP <800> guidelines. Choice B is incorrect because a CACI provides containment but does not eliminate PPE needs, as exposure can occur from residues or breaches, a common error in assuming engineering controls suffice alone; choice C is suboptimal because one pair of nonsterile gloves and a mask offer inadequate barrier protection for HDs, risking occupational exposure; choice D is wrong because it prioritizes respiratory protection over comprehensive dermal safeguards, overlooking the primary exposure route for most HDs. A transferable sterile compounding pearl is to always layer engineering controls, administrative measures, and PPE for HD handling to prevent exposure. Proper PPE guidelines under USP <800> include donning in a specific order—gown, gloves, etc.—and doffing carefully to avoid contamination.
  2. A 29-year-old female (62 kg) with Crohn disease is ordered ustekinumab 390 mg IV induction dose. Allergies: none. Labs: SCr 0.7 mg/dL, AST 18 units/L, ALT 16 units/L, WBC 6,700/mm3^3. Current medications: prednisone 20 mg by mouth daily, pantoprazole 40 mg by mouth daily. The biologic will be prepared as an IV infusion in an ISO Class 5 PEC within an ISO Class 7 buffer room and administered later the same day. Which environmental condition is crucial for this preparation?
    Answer: An ISO Class 5 PEC is required to provide unidirectional HEPA-filtered airflow over critical sites during compounding The concept being tested is environmental requirements for biologic sterile preparations. The key factor is the need for controlled airflow during ustekinumab infusion preparation for the Crohn disease patient. Choice A is the best because an ISO Class 5 PEC provides essential HEPA-filtered air over critical sites, ensuring sterility and safety. Choice B is incorrect as ISO Class 9 lacks sufficient control, even for short use, risking particulates. Choices C and D are suboptimal because negative pressure is for hazardous drugs, and segregated areas limit BUDs unnecessarily. A transferable pearl is to monitor pressure differentials daily in cleanroom suites. Proper aseptic technique avoids rapid movements that disrupt airflow.
  3. A 69-year-old male (83 kg) with heart failure is ordered a continuous IV infusion of bumetanide prepared as 12.5 mg in 50 mL 0.9% sodium chloride in a syringe for a pump. Allergies: none. Labs: SCr 2.0 mg/dL, AST 26 units/L, ALT 23 units/L, WBC 7,200/mm3^3. Current medications: carvedilol 12.5 mg by mouth twice daily, spironolactone 25 mg by mouth daily. The syringe is prepared in an ISO Class 5 PEC in an ISO Class 7 buffer room and will be refrigerated for use tomorrow. What is the appropriate beyond-use date for this compound?
    Answer: 48 hours refrigerated because it is a low-risk CSP The concept being tested is beyond-use date (BUD) for low-risk compounded sterile preparations (CSPs) in syringes stored refrigerated. The key factor is refrigerated storage of the bumetanide syringe infusion prepared in an ISO Class 5 PEC for next-day use in heart failure. Choice A is the best because 48 hours refrigerated meets low-risk guidelines for syringe preparations, ensuring diuretic stability and patient safety. Choice B is incorrect as 24 hours is unnecessarily short, reducing efficiency. Choices C and D are suboptimal because 7 days or 12 hours do not align with risk level or storage. A transferable pearl is to protect syringes from light if drug-sensitive. Proper aseptic technique avoids overfilling to prevent pressure buildup.
  4. A 38-year-old male (78 kg) is ordered an IV push dose of morphine 4 mg for acute pain. Allergies: none. Labs: SCr 0.9 mg/dL, AST 19 units/L, ALT 21 units/L, WBC 8,200/mm3^3. Current medications: ketorolac 15 mg IV every 6 hours as needed, lactated Ringer's at 75 mL/hour. A technician draws morphine from a single-dose vial into a syringe in an ISO Class 5 PEC, but then places the uncapped syringe on the counter in the ISO Class 8 anteroom for 20 minutes before labeling. Which technique ensures sterility in this preparation?
    Answer: Maintain the prepared syringe within the ISO Class 5 PEC (or otherwise protected) until it is capped, labeled, and ready for transport The concept being tested is maintaining sterility during sterile compounding processes. The key factor is the exposure of an uncapped syringe in the ISO Class 8 anteroom, compromising asepsis for the morphine dose. Choice B is the best because keeping the syringe in the ISO Class 5 PEC until capped protects against contamination, ensuring product integrity and patient safety. Choice A is incorrect as leaving uncapped in the anteroom introduces particles, a common error in workflow. Choices C and D are suboptimal because recapping outside or prohibiting labeling ignores proper procedures, leading to waste or errors. A transferable pearl is to perform all uncapped manipulations inside the PEC. Proper PPE sequence involves hand hygiene before donning gloves in the clean area.
  5. A 6-year-old male (20 kg) with acute lymphoblastic leukemia is scheduled for vincristine 1.2 mg IV today (hazardous drug). Allergies: none. Labs: SCr 0.4 mg/dL, AST 20 units/L, ALT 16 units/L, WBC 2,100/mm3^3, platelets 85,000/mm3^3. Current medications: trimethoprim-sulfamethoxazole 80/400 mg by mouth twice daily on weekends, ondansetron 4 mg by mouth every 8 hours as needed. The dose will be compounded in a negative-pressure ISO Class 7 hazardous buffer room using an ISO Class 5 biological safety cabinet (BSC) and transported to the infusion center. Which personal protective equipment is required for this preparation?
    Answer: Two pairs of chemotherapy gloves and a chemotherapy gown; add eye/face protection if splash risk exists The concept being tested is personal protective equipment (PPE) requirements for handling hazardous drugs under USP <800>. The key factor is the hazardous nature of vincristine, requiring enhanced protection during compounding in a biological safety cabinet (BSC) for the pediatric leukemia patient. Choice B is the best because two pairs of chemotherapy gloves and a chemotherapy gown provide barrier protection against exposure, with eye/face protection added for splash risks, ensuring personnel and patient safety. Choice A is incorrect as one pair of gloves and optional gown underestimate hazardous drug risks, even in a BSC, leading to potential contamination. Choices C and D are suboptimal because minimal gloves/hair cover ignore full PPE needs, and N95 is for airborne hazards not primary for vincristine, common errors in hazardous compounding. A transferable pearl is to always use USP <800>-compliant PPE for hazardous drugs, including double gloving and dedicated gowns. Proper aseptic technique involves maintaining negative pressure in hazardous buffer rooms to contain contaminants.
  6. A 56-year-old female (65 kg) with rheumatoid arthritis is ordered tocilizumab 480 mg IV. Allergies: none. Labs: SCr 0.8 mg/dL, AST 48 units/L, ALT 55 units/L, WBC 3,600/mm3^3. Current medications: methotrexate 15 mg by mouth weekly, folic acid 1 mg by mouth daily, prednisone 5 mg by mouth daily. The infusion will be compounded in an ISO Class 5 PEC within an ISO Class 7 buffer room and delivered to an outpatient infusion suite. Which technique ensures sterility in this preparation?
    Answer: Disinfect the vial stopper and the IV bag port with sterile 70% isopropyl alcohol using friction and allow to dry before each access The concept being tested is disinfection techniques for multi-component sterile infusions. The key factor is repeated access to vial and bag ports during tocilizumab compounding for the rheumatoid arthritis patient. Choice A is the best because friction with 70% isopropyl alcohol and drying before access prevents microbial entry, ensuring infusion sterility and safety. Choice B is incorrect as nonsterile gloves compromise asepsis, a common garbing error. Choices C and D are suboptimal because keeping used syringes or touching ports introduces contaminants. A transferable pearl is to disinfect in a pecking motion for thorough coverage. Proper framework follows ISO classifications to maintain air quality.
  7. A 45-year-old male (95 kg) with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is ordered daptomycin 600 mg IV now. Allergies: none. Labs: SCr 1.3 mg/dL, creatine kinase 110 units/L, AST 24 units/L, ALT 19 units/L, WBC 14,200/mm3^3. Current medications: atorvastatin 40 mg by mouth nightly, normal saline at 100 mL/hour. The dose is compounded from a single-dose vial, diluted in 50 mL of 0.9% sodium chloride, and will be stored at room temperature on the unit for administration during rounds. What is the appropriate beyond-use date for this compound?
    Answer: 12 hours at controlled room temperature because it is a low-risk CSP The concept being tested is assigning beyond-use dates (BUDs) for low-risk compounded sterile preparations (CSPs) stored at room temperature. The key factor is the room temperature storage of the daptomycin infusion prepared from a single-dose vial for a patient with MRSA bacteremia. Choice B is the best because 12 hours at controlled room temperature matches low-risk CSP guidelines, preventing microbial growth and ensuring safety for prompt administration. Choice A is incorrect as 1 hour is for immediate-use only, not applicable here, leading to unnecessary waste. Choices C and D are suboptimal because 24 hours or 14 days exceed low-risk limits for room temperature, risking contamination, common errors in BUD miscalculation. A transferable pearl is to consider drug-specific stability alongside USP <797> risk levels when assigning BUDs. Proper aseptic technique requires avoiding contact with critical sites and using sterile 70% isopropyl alcohol for disinfection.
  8. A 34-year-old female (64 kg) is ordered methotrexate 25 mg intrathecal (hazardous drug) for leukemia. Allergies: none. Labs: SCr 0.6 mg/dL, AST 22 units/L, ALT 18 units/L, WBC 1,900/mm3^3. Current medications: leucovorin per protocol, acyclovir prophylaxis. The dose will be prepared in an ISO Class 5 BSC in a negative-pressure ISO Class 7 hazardous buffer room and dispensed in a syringe with a needleless cap. Which personal protective equipment is required for this preparation?
    Answer: Two pairs of chemotherapy gloves, chemotherapy gown, and head/hair cover; add eye/face protection if splash risk exists The concept being tested is PPE requirements for hazardous intrathecal preparations under USP <800>. The key factor is the hazardous status of methotrexate, necessitating full protection for intrathecal compounding in a BSC. Choice A is the best because two pairs of chemotherapy gloves, gown, and head cover prevent exposure, with eye protection for splashes, ensuring safety for the leukemia patient. Choice B is incorrect as non-chemotherapy PPE underprotects against hazardous residues. Choices C and D are suboptimal because mask alone or single gloves ignore comprehensive needs, common PPE errors. A transferable pearl is to doff outer gloves before exiting the buffer room. Proper framework includes annual competency assessments for hazardous compounding.
  9. A 27-year-old male (70 kg) with sickle cell pain crisis is ordered hydromorphone patient-controlled analgesia (PCA) syringe: hydromorphone 30 mg in 30 mL (1 mg/mL). Allergies: none. Labs: SCr 0.7 mg/dL, AST 24 units/L, ALT 20 units/L, WBC 13,000/mm3^3. Current medications: ketorolac 15 mg IV every 6 hours as needed, hydroxyurea 1,000 mg by mouth daily. The PCA syringe is compounded in an ISO Class 5 PEC in an ISO Class 7 buffer room. What is the most critical step in preparing this sterile product?
    Answer: Independently verify the calculation and final concentration (1 mg/mL) before dispensing to prevent dosing error The concept being tested is verification steps in high-risk opioid compounding. The key factor is the concentrated hydromorphone PCA syringe, requiring accuracy to prevent overdose in the sickle cell patient. Choice B is the best because independent verification of calculation and concentration minimizes errors, ensuring safe pain management. Choice A is incorrect as filtering does not verify dosing, missing error prevention. Choices C and D are suboptimal because anteroom preparation violates classification, and large needles increase coring risks. A transferable pearl is to use double-checks for high-alert medications like opioids. Proper PPE includes gloves compatible with controlled substances.
  10. A 70-year-old female (66 kg) with Clostridioides difficile infection is ordered fidaxomicin by mouth, but she cannot swallow; the team requests oral vancomycin solution prepared from vancomycin powder for injection reconstituted with sterile water and then further diluted for enteral administration. Allergies: none. Labs: SCr 1.2 mg/dL, AST 20 units/L, ALT 17 units/L, WBC 15,500/mm3^3. The pharmacy plans to compound the solution in the nonsterile compounding area. Which environmental condition is crucial for this preparation?
    Answer: A nonsterile compounding area is acceptable because the final dosage form is intended for enteral administration, not parenteral use The concept being tested is appropriate environmental conditions for nonsterile preparations using sterile components. The key factor is the enteral administration of vancomycin solution prepared from injectable powder for the patient unable to swallow. Choice C is the best because nonsterile areas suffice for non-parenteral products, ensuring practicality without overclassifying and maintaining safety. Choice A is incorrect as ISO Class 5 is unnecessary for oral use, increasing costs. Choices B and D are suboptimal because negative pressure is for hazardous, and buffer rooms are for sterile preparations. A transferable pearl is to distinguish sterile vs. nonsterile based on route of administration. Proper technique includes accurate measuring for oral solutions to avoid dosing errors.
  11. A 65-year-old female (59 kg) is receiving ganciclovir 5 mg/kg IV every 12 hours for cytomegalovirus infection (hazardous drug per many institutional policies). Allergies: none. Labs: SCr 1.6 mg/dL, AST 28 units/L, ALT 26 units/L, WBC 2,400/mm3^3. Current medications: tacrolimus, mycophenolate, prednisone. The pharmacy compounds ganciclovir doses in an ISO Class 5 PEC located in a negative-pressure hazardous buffer room and uses hazardous drug labeling for transport. Which personal protective equipment is required for this preparation?
    Answer: Two pairs of chemotherapy gloves and a chemotherapy gown; add eye/face protection if splash risk exists The sterile preparation concept being tested is the personal protective equipment (PPE) required for compounding non-antineoplastic hazardous drugs like ganciclovir in a hazardous drug setting. The key preparation-specific factor is that ganciclovir is classified as hazardous due to reproductive risks per NIOSH and institutional policies, necessitating handling in a negative-pressure hazardous buffer room. Choice B is the best choice for ensuring sterile integrity and patient safety because it requires two pairs of chemotherapy gloves and a chemotherapy gown to prevent dermal exposure to hazardous residues, with added eye/face protection for splash risks, aligning with USP <800> for HDs. Choice A is incorrect because, despite not being antineoplastic, ganciclovir's hazardous status demands full PPE, not just sterile gloves, to avoid exposure errors; choice C is suboptimal as gloves are mandatory for all aseptic HD compounding to maintain barriers, even in an ISO Class 5 PEC; choice D is wrong because it ignores glove and gown needs, focusing on less critical areas while dermal contact remains a primary concern. A transferable sterile compounding pearl is to review the NIOSH hazardous drug list and perform risk assessments for each agent to tailor PPE appropriately. Frameworks like USP <800> emphasize combining PPE with engineering controls, such as PECs in buffer rooms, and proper technique to safeguard personnel and preparations.
  12. A 76-year-old male (74 kg) with sepsis is ordered norepinephrine 8 mg in 250 mL D5W as a continuous IV infusion. Allergies: none. Labs: SCr 1.8 mg/dL, AST 40 units/L, ALT 33 units/L, WBC 19,000/mm3^3. Current medications: vasopressin infusion, meropenem 1 g IV every 8 hours. The pharmacy will batch compound multiple norepinephrine bags for the ICU using an ISO Class 5 PEC in an ISO Class 7 buffer room, and store them refrigerated until needed. What is the appropriate beyond-use date for this compound?
    Answer: 48 hours refrigerated because it is a low-risk CSP The concept being tested is beyond-use date (BUD) assignment for batched low-risk compounded sterile preparations (CSPs) stored refrigerated. The key factor is the batch compounding of norepinephrine infusions in an ISO Class 5 PEC for ICU use in a septic patient. Choice B is the best because 48 hours refrigerated fits low-risk CSP guidelines for batched items, balancing stability and safety. Choice A is incorrect as 24 hours underestimates allowable time, potentially increasing workload. Choices C and D are suboptimal because 7 or 28 days exceed low-risk limits without testing, risking degradation. A transferable pearl is to protect light-sensitive drugs like norepinephrine during storage. Proper aseptic technique includes using friction when disinfecting with 70% isopropyl alcohol.
  13. A 60-year-old female (72 kg) with ovarian cancer is ordered paclitaxel 175 mg/m2^2 IV (hazardous drug) in a non-polyvinyl chloride (non-PVC) container. Allergies: none. Labs: SCr 0.9 mg/dL, AST 31 units/L, ALT 28 units/L, WBC 4,000/mm3^3. Current medications: diphenhydramine 50 mg IV, famotidine 20 mg IV, dexamethasone 20 mg IV as premedications. The dose will be compounded in an ISO Class 5 BSC in a negative-pressure ISO Class 7 hazardous buffer room. What is the correct procedure to handle this hazardous drug?
    Answer: Use a closed-system drug-transfer device when possible and dispose of all materials as hazardous drug waste per facility policy The concept being tested is handling procedures for hazardous drugs in non-PVC containers under USP <800>. The key factor is the hazardous classification of paclitaxel, requiring containment strategies during compounding for the ovarian cancer patient. Choice B is the best because using a CSTD and proper waste disposal minimizes exposure risks, promoting safety for personnel and environment. Choice A is incorrect as positive-pressure rooms allow contaminant escape, unsuitable for hazardous drugs. Choices C and D are suboptimal because preparing outside BSC or omitting chemo gloves increases risks, common handling errors. A transferable pearl is to use dedicated equipment for hazardous drugs. Proper aseptic technique in negative-pressure rooms protects both product and operator.
  14. A 50-year-old male (90 kg) with invasive fungal infection is ordered liposomal amphotericin B 300 mg IV. Allergies: none. Labs: SCr 2.2 mg/dL, potassium 3.1 mEq/L, magnesium 1.4 mg/dL, AST 29 units/L, ALT 24 units/L, WBC 2,900/mm3^3. Current medications: potassium chloride supplementation, magnesium sulfate supplementation. The product is reconstituted and further diluted for infusion in an ISO Class 5 PEC in an ISO Class 7 buffer room. Which technique ensures sterility in this preparation?
    Answer: Swab vial stoppers with 70% isopropyl alcohol and allow to dry before each entry, even if entered previously The concept being tested is aseptic techniques for multi-entry vials in sterile compounding. The key factor is repeated access to the amphotericin B vial during reconstitution for the fungal infection patient. Choice A is the best because disinfecting before each entry reduces microbial risk, maintaining sterility and patient safety. Choice B is incorrect as skipping disinfection even for new vials invites contamination, a common oversight. Choices C and D are suboptimal because touching tips or reusing needles breaches asepsis, leading to errors. A transferable pearl is to use a new sterile needle and syringe for each vial access. Proper PPE includes face masks to prevent droplet contamination in the PEC.
  15. A 61-year-old male (86 kg) with pulmonary embolism is ordered a heparin infusion prepared as 25,000 units in 250 mL of 0.45% sodium chloride. Allergies: none. Labs: SCr 1.0 mg/dL, AST 21 units/L, ALT 20 units/L, WBC 9,100/mm3^3, platelets 210,000/mm3^3. Current medications: aspirin 81 mg by mouth daily, atorvastatin 20 mg by mouth nightly. The infusion is compounded from a heparin vial into a minibag in an ISO Class 5 PEC and will be stored at room temperature for use within the day. What is the appropriate beyond-use date for this compound?
    Answer: 12 hours at controlled room temperature because it is a low-risk CSP The concept being tested is beyond-use date (BUD) for low-risk compounded sterile preparations (CSPs) at room temperature. The key factor is room temperature storage of the heparin infusion compounded in an ISO Class 5 PEC for the pulmonary embolism patient. Choice A is the best because 12 hours at controlled room temperature adheres to low-risk guidelines, preventing coagulation issues and ensuring safety. Choice B is incorrect as 24 hours may exceed limits without specified conditions, risking instability. Choices C and D are suboptimal because 48 hours or 7 days overestimate for room temperature, common BUD errors. A transferable pearl is to label CSPs with BUD and storage requirements clearly. PPE guidelines emphasize double gloving for anticoagulants to avoid skin contact.
  16. A 58-year-old male (80 kg) receiving chemotherapy develops nausea and is ordered aprepitant IV (fosaprepitant) 150 mg infusion. Allergies: none. Labs: SCr 0.9 mg/dL, AST 33 units/L, ALT 29 units/L, WBC 3,800/mm3^3. Current medications: cisplatin, dexamethasone, ondansetron. The pharmacy is compounding the antiemetic infusion in an ISO Class 5 PEC in an ISO Class 7 buffer room (nonhazardous compounding suite). Which technique ensures sterility in this preparation?
    Answer: Arrange supplies to avoid blocking first air to critical sites and avoid working directly above open ports The concept being tested is workspace arrangement for aseptic technique in nonhazardous compounding. The key factor is preventing obstruction of first air during aprepitant infusion preparation for the chemotherapy patient. Choice A is the best because proper arrangement avoids blocking critical sites, ensuring HEPA air protection and product sterility. Choice B is incorrect as working at the edge reduces effective airflow, a common positioning error. Choices C and D are suboptimal because spraying into hubs or using nonsterile gauze introduces contaminants. A transferable pearl is to stage items from dirtiest to cleanest in the PEC. Proper aseptic framework involves visual inspection for particulates before dispensing.
  17. A 67-year-old male (82 kg) with pneumonia is ordered vancomycin 1.5 g intravenous (IV) now, to be infused over 2 hours. Allergies: none. Labs: serum creatinine (SCr) 1.1 mg/dL, aspartate aminotransferase (AST) 22 units/L, alanine aminotransferase (ALT) 18 units/L, white blood cell count (WBC) 16,000/mm3^3. Current medications: piperacillin-tazobactam 4.5 g IV every 6 hours, acetaminophen 650 mg by mouth every 6 hours as needed. The dose must be compounded urgently in an ISO Class 5 primary engineering control (PEC) located in an ISO Class 7 buffer room with an ISO Class 8 anteroom; the pharmacy plans to prepare it as a single-dose syringe for IV pump administration. Which technique ensures sterility in this preparation?
    Answer: Perform all critical manipulations at least 6 inches inside the ISO Class 5 PEC, keeping first air unobstructed to vial stoppers and syringe tips The concept being tested is proper aseptic technique in an ISO Class 5 primary engineering control (PEC) for compounding sterile preparations. The key factor is maintaining the integrity of first air (unidirectional HEPA-filtered air) to critical sites during urgent compounding of vancomycin for a patient with pneumonia. Choice A is the best because performing manipulations at least 6 inches inside the PEC and keeping first air unobstructed ensures direct protection of vial stoppers and syringe tips from contamination, promoting patient safety. Choice B is incorrect because disinfecting with sterile water lacks antimicrobial efficacy compared to sterile 70% isopropyl alcohol, leading to potential microbial growth. Choices C and D are suboptimal as placing items against the back grill can obstruct airflow, and opening supplies outside the PEC introduces contaminants, both common errors in aseptic technique. A transferable pearl is to always ensure critical sites receive direct first air without interruption during compounding. Proper PPE and hand hygiene are foundational to aseptic technique, including donning sterile gloves after entering the buffer room.
  18. A 41-year-old male (76 kg) with bacterial meningitis is ordered ceftriaxone 2 g IV every 12 hours; the next dose is needed in 30 minutes. Allergies: none. Labs: SCr 0.8 mg/dL, AST 20 units/L, ALT 22 units/L, WBC 18,600/mm3^3. Current medications: dexamethasone 10 mg IV every 6 hours, acetaminophen 650 mg by mouth as needed. The pharmacy plans to compound a ceftriaxone minibag in a segregated compounding area (SCA) using an ISO Class 5 PEC because the buffer room is temporarily unavailable; the dose will be administered immediately after preparation. Which environmental condition is crucial for this preparation?
    Answer: Compounding in an SCA is acceptable if an ISO Class 5 PEC is used and the CSP is assigned a shorter beyond-use date per USP <797> The concept being tested is use of segregated compounding areas (SCAs) for urgent sterile preparations. The key factor is the temporary unavailability of the buffer room, necessitating SCA use for immediate ceftriaxone administration in meningitis. Choice A is the best because SCA with ISO Class 5 PEC allows compounding with shortened BUD per USP <797>, ensuring timely therapy and safety. Choice B is incorrect as SCA is permitted for Category 1 CSPs, not prohibited. Choices C and D are suboptimal because requiring buffer rooms or anterooms ignores SCA provisions, delaying care. A transferable pearl is to assign 12-hour RT BUD for Category 1 CSPs in SCAs. Proper framework includes daily cleaning of PECs in SCAs.
  19. A 3-day-old premature neonate (1.2 kg) in the neonatal intensive care unit requires a customized total parenteral nutrition (TPN) bag. Allergies: none. Labs: SCr 0.6 mg/dL, AST 35 units/L, ALT 18 units/L, total bilirubin 6.2 mg/dL, WBC 9,500/mm3^3, potassium 3.4 mEq/L, magnesium 1.6 mg/dL, phosphate 3.0 mg/dL. Current medications: ampicillin 50 mg/kg IV every 12 hours, gentamicin 4 mg/kg IV every 24 hours. The TPN will be compounded in an ISO Class 5 PEC within an ISO Class 7 buffer room and includes calcium gluconate and sodium phosphate additives. What is the most critical step in preparing this sterile product?
    Answer: Verify calcium and phosphate compatibility and add them in an order that reduces precipitation risk (typically phosphate first, calcium later) The concept being tested is preventing incompatibility in total parenteral nutrition (TPN) compounding. The key factor is the risk of calcium phosphate precipitation in the customized TPN for a premature neonate with specific electrolyte needs. Choice B is the best because verifying compatibility and adding phosphate first then calcium minimizes precipitation, ensuring solution stability and patient safety. Choice A is incorrect as adding them simultaneously increases precipitation risk, a common error in hurried compounding. Choices C and D are suboptimal because sodium chloride may not prevent issues, and filtering does not address root causes, potentially clogging lines. A transferable pearl is to use compatibility charts and sequential addition for electrolytes in TPN. Proper PPE includes sterile gloves and gowns in the buffer room to maintain asepsis.
  20. A 52-year-old male (100 kg) with diabetic ketoacidosis is ordered an insulin infusion prepared as regular insulin 100 units in 100 mL of 0.9% sodium chloride. Allergies: none. Labs: SCr 1.0 mg/dL, potassium 5.6 mEq/L, bicarbonate 12 mEq/L, WBC 12,300/mm3^3. Current medications: potassium replacement per protocol, normal saline boluses. The infusion is compounded in an ISO Class 5 PEC in an ISO Class 7 buffer room and will be hung immediately. Which technique ensures sterility in this preparation?
    Answer: Use a sterile alcohol pad to disinfect the bag's injection port and allow it to dry before injecting insulin The concept being tested is aseptic techniques for insulin infusion compounding. The key factor is disinfecting the IV bag port before injecting insulin for the diabetic ketoacidosis patient. Choice A is the best because using sterile alcohol and allowing drying kills microbes, preventing contamination and ensuring infusion safety. Choice B is incorrect as post-injection disinfection does not prevent initial entry of contaminants. Choices C and D are suboptimal because tap water or touching hubs breaches sterility, common technique errors. A transferable pearl is to use luer-lock connections to secure infusions. Proper PPE guidelines prohibit jewelry in compounding areas to reduce bioburden.

Start this quiz